FR2332756A1 - Nouvelles 1, 4-benzoxazin-3(4h)-ones - Google Patents

Nouvelles 1, 4-benzoxazin-3(4h)-ones

Info

Publication number
FR2332756A1
FR2332756A1 FR7635608A FR7635608A FR2332756A1 FR 2332756 A1 FR2332756 A1 FR 2332756A1 FR 7635608 A FR7635608 A FR 7635608A FR 7635608 A FR7635608 A FR 7635608A FR 2332756 A1 FR2332756 A1 FR 2332756A1
Authority
FR
France
Prior art keywords
benzoxazin
news
ones
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7635608A
Other languages
English (en)
Inventor
John Krapcho
Chester Frank Turk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ER Squibb and Sons LLC
Original Assignee
ER Squibb and Sons LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ER Squibb and Sons LLC filed Critical ER Squibb and Sons LLC
Publication of FR2332756A1 publication Critical patent/FR2332756A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
    • C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
    • C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7635608A 1975-11-26 1976-11-25 Nouvelles 1, 4-benzoxazin-3(4h)-ones Withdrawn FR2332756A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US63550475A 1975-11-26 1975-11-26
US63575875A 1975-11-26 1975-11-26
US66412376A 1976-03-05 1976-03-05

Publications (1)

Publication Number Publication Date
FR2332756A1 true FR2332756A1 (fr) 1977-06-24

Family

ID=27417565

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7635608A Withdrawn FR2332756A1 (fr) 1975-11-26 1976-11-25 Nouvelles 1, 4-benzoxazin-3(4h)-ones

Country Status (4)

Country Link
US (1) US4107167A (fr)
JP (1) JPS5265280A (fr)
DE (1) DE2653819A1 (fr)
FR (1) FR2332756A1 (fr)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0441539A2 (fr) * 1990-02-08 1991-08-14 Tanabe Seiyaku Co., Ltd. Dérivés de thiazine (ou oxazine) et leur préparation
US5496815A (en) * 1990-02-08 1996-03-05 Tanabe Seiyaku Co., Ltd. Thiazine (or oxazine) derivatives and preparation thereof
WO1999050257A1 (fr) * 1998-03-31 1999-10-07 Warner-Lambert Company Benzoxazinones/benzothiazinones utilisees comme inhibiteurs de serines-proteases

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4252945A (en) * 1979-07-11 1981-02-24 E. R. Squibb & Sons, Inc. Process for preparing pyrazolo[1,5-c]-quinazoline derivatives and novel intermediates
WO1995018115A1 (fr) * 1993-12-28 1995-07-06 Santen Pharmaceutical Co., Ltd. Derive de 3-oxo-1,4-benzoxazine
CN102325531B (zh) * 2008-12-19 2014-04-02 健泰科生物技术公司 化合物和使用方法
US8940737B2 (en) 2011-10-14 2015-01-27 Abbvie Inc. Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
CN103987711B (zh) 2011-10-14 2016-08-24 艾伯维公司 作为用于治疗癌症和免疫性和自身免疫性疾病的凋亡诱导剂的8-氨基甲酰基-2-(2,3-二取代吡啶-6-基)-1,2,3,4-四氢异喹啉衍生物

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0441539A2 (fr) * 1990-02-08 1991-08-14 Tanabe Seiyaku Co., Ltd. Dérivés de thiazine (ou oxazine) et leur préparation
EP0441539A3 (en) * 1990-02-08 1992-04-15 Tanabe Seiyaku Co., Ltd. Thiazine (or oxazine) derivatives and preparation thereof
US5246929A (en) * 1990-02-08 1993-09-21 Tanabe Seiyaku Co., Ltd. Naphtho thiazine (or oxaline) derivatives and preparations thereof
US5281592A (en) * 1990-02-08 1994-01-25 Tanabe Seiyaku Co., Ltd. Thiazine derivatives and preparation thereof
US5496815A (en) * 1990-02-08 1996-03-05 Tanabe Seiyaku Co., Ltd. Thiazine (or oxazine) derivatives and preparation thereof
WO1999050257A1 (fr) * 1998-03-31 1999-10-07 Warner-Lambert Company Benzoxazinones/benzothiazinones utilisees comme inhibiteurs de serines-proteases
US6509335B1 (en) 1998-03-31 2003-01-21 Warner-Lambert Company Benzoxazinoes/benzothiazinones as serine protease inhibitors

Also Published As

Publication number Publication date
JPS5265280A (en) 1977-05-30
DE2653819A1 (de) 1977-06-02
US4107167A (en) 1978-08-15

Similar Documents

Publication Publication Date Title
BE857191A (fr) Nouvelles 1,2,4,5-tetrahydro-3h-2-benzazepine-3-ones
NL161109C (nl) Buisvormige houder.
TR21512A (tr) 4h-3,1 benzoksazin tuerevleri
BE861853A (fr) Nouvelles piperazines
FR2342735A1 (fr) Nouvelles imidazodiazepines
NL7606531A (nl) Houder.
NL7514307A (nl) Zakrichtmachine.
BE853027A (fr) Nouvelles n-oxy-amidino-urees
BE850688A (fr) Nouvelles 1,2-benzisothiazolinones-3
DK587476A (da) 1,4-benzoxazin- og 1,4-benzothiazinderivater samt fremgangsmade til fremstilling deraf
BE859987A (fr) Nouvelles aza-8 purinones-6
FR2313362A1 (fr) Nouvelles 4-oxoazetidines
SE7604095L (sv) 4,4-dihydrospiro-2h-1,3-bensoxaziner
FR2332756A1 (fr) Nouvelles 1, 4-benzoxazin-3(4h)-ones
BE858682A (fr) Nouvelles 11-deoxy-11-oxaprostaglandines
BE847582A (fr) Nouvelles quinacridones,
SE422898B (sv) Brotschningsverktyg
BE847688A (fr) Pieces compactes diamantees,
FR2297628A1 (fr) 2,3-dihydroergolines
BE862927A (fr) Nouvelles sulfonylhydrazones de 1,4-dioxo- et 4-oxoquinoxaline-2-carboxaldehyde
NL7613005A (nl) Buisvormige molen.
SE7608452L (sv) 2,4-diamino-5-benzylpyrimidiner
BE842782A (fr) 4,5-dihydrotetrazolo (1,5-a)- quinoxalines
BE844697A (fr) Ar-octahalodiphenyl-ether-4,4'-dimethanol
DK534976A (da) Substituerede 2,1,3-benzothiadiazin-forbindelser

Legal Events

Date Code Title Description
ST Notification of lapse